The Hematology Analyzers and Reagents Market Is Expected To Register A CAGR Of About 7%, During the Forecast Period 2018 To 2026 According to Analysts at Healthcare Intelligence Markets.
An increase in the incidences of blood related disorders has resulted in an increased adoption of hematology. A growing trend called as immunohematology has integrated flow cytometry techniques with analyzers that has brought in shift from manual testing to automated testing. The growing number of blood donation campaigns is a major factor driving the growth of the market. All these techniques have helped practitioners in screening and examining the disease more accurately, and has therefore led to an extensive use by doctors and lab technicians across the globe.
The rising awareness related to the availability and benefits of hematology techniques has resulted this market to Grow at a Sustainable Rate All the prominent features such as the key trends, pitfalls, and other industry-specific challenges are described in details. It has identified that North America region is generating the highest market share.
For Sample Copy of this report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=29003
The competitive landscape of the global implants market has demonstrated the presence of key players such as Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Agilent Technologies Inc., Dolomite Centre, F. Hoffmann-La Roche Fluidigm Corporation, Micronit Microfluidics BV, AG, PerkinElmer Inc., Thermo Fisher Scientific Inc., and uFluidix, among others. In January 2018, Abbott Laboratories launched Alinity H-Series, integrating testing mechanism with a standalone analyzer therefore, reducing errors and operating costs. They have also launched CELL-DYN Sapphire, CELL-DYN Ruby, CELL-DYN Emerald and CELL-DYN Emerald 22 for streamlining workflow in high- volume hematology laboratories.
The hematology devices has integrated workflow in laboratories by rendering a single platform and has reduced hands-on time spent by operators. This factor has majorly implored the market growth. The unaffordability of hematology analyzers in the emerging countries like India and China is hindering its proliferation in this region. The hematology market has witnessed a shift towards automation and is emerging as a vital industry, which is anticipated to drive the future demands.
Avail Discount on this report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29003
Hematology Analyzers and Reagents Market – by Application
• Blood Cancer
• Hemorrhagic Conditions
• Infection Related Conditions
• Immune System Related Conditions
Hematology Analyzers and Reagents Market – by End-User
• Commercial Service Providers
• Reference Laboratories
• Research and Academic Institutes
Hematology Analyzers and Reagents Market – by Region
• North America
• Rest of North America
• The UK
• Rest of Europe
• Asia Pacific
• Southeast Asia
• Rest of Asia Pacific
• Middle East and Africa
• GCC Countries
• Southern Africa
• Rest of Middle East and Africa
• Latin America
• Rest of Latin America
Hematology Analyzers and Reagents Market report provides both, qualitative and quantitative research of the market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.